¿Û¿Û´«Ã½

What went wrong for Life Science Reit

Its IPO was oversubscribed, but it now trades at a discount. Is there any way back for loyal investors?

Retail is having a renaissance – and this Reit is taking advantage

Retail used to be a dirty word in property but if you pick the right brands in the right location, your strategy can be on point

Activism in the property sector – who will be next?

Activists and private equity are circling the listed property sector

Land Securities’ transformation hit by lacklustre office market

A lack of deals in London’s office market means the welcomed change in portfolio mix is taking time

PHP enters the Assura buyout saga

Harry Hyman tells the Investors’ Chronicle why PHP’s offer allows Assura shareholders to ‘preserve some upside’

What investors should make of the bid for Assura

Private equity has the £3.1bn healthcare portfolio in its sights

Reits taking advantage of rising care home demand

Ageing populations and low supply – the fundamentals are stacked in care home investors' favour

Why the office property market is brightening up

High quality offices in prime central London are back to having very low vacancy rates

The worst is over for Reits – but it still pays to pick wisely

FTSE 350 Review: Another year of consolidation awaits investors, and scale will become even more important

Why it's time to rethink retail property

There are more ways to invest than shopping centres – we pick out the best ways to buy back into this bargain space